However, AML patients high c-Myc-immunopositivity were younger (41.58 ± 14.88 vs. 44.37 ± 51.29 years; p = 0.031) and had more leukocytosis (90.10 ± 61.26 vs. 44.37 ± 51.29 (103/μL); p = 0.002) than those without high c-Myc-immunopositivity (Table 2). This evidence concerns the gene MYC and Increased total leukocyte count.